Summary
This 8-K filing from Quest Diagnostics Incorporated (DGX), dated February 28, 2003, primarily serves to disclose that the company's Chief Executive Officer, Kenneth W. Freeman, and Chief Financial Officer, Robert A. Hagemann, submitted sworn statements to the Securities and Exchange Commission (SEC) on February 27, 2003. These statements were made in accordance with Section 906 of the Sarbanes-Oxley Act of 2002, which mandates CEO and CFO certifications for periodic reports filed with the SEC. While this filing does not contain any new financial results or significant business updates, it is important for investors as it confirms the company's compliance with the recently enacted Sarbanes-Oxley Act. This legislation introduced stricter corporate governance and financial reporting standards, aiming to enhance transparency and accountability. The submission of these sworn statements indicates Quest Diagnostics' adherence to these new regulatory requirements.
Key Highlights
- 1Quest Diagnostics Incorporated filed an 8-K Current Report on February 28, 2003.
- 2The report confirms compliance with Section 906 of the Sarbanes-Oxley Act of 2002.
- 3CEO Kenneth W. Freeman submitted a sworn statement.
- 4CFO Robert A. Hagemann submitted a sworn statement.
- 5The sworn statements were submitted to the SEC on February 27, 2003.
- 6This filing relates to corporate governance and financial reporting compliance.
- 7No new financial results or operational updates are disclosed in this filing.